BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Lone Star Bio

  Virbac S.A. Extends Cash Tender Offer For All Publicly Held Shares Of Virbac Corporation

  September 15, 2006

   · 

  1 min read
• Drug Development

  Molecular Biomarkers Predicting Efficacy Of Introgen Therapeutics, Inc.'s ADVEXIN Cancer Therapy Are Highlighted At Major Cancer Conference

  September 15, 2006

   · 

  1 min read
• Drug Development

  CepTor Corporation Executes LOI With Ferring For Late Stage Product; Superoxide Dismutase Targeted For Phase 2B Clinical Trials

  September 15, 2006

   · 

  1 min read
• Business

  The Immune Response Corporation, Inc. Announces Addition Of James L. Foght, Ph.D., To Board Of Directors

  September 15, 2006

   · 

  1 min read
• Genetown

  pSivida Limited Completes Agreement With Existing Convertible Note Holder

  September 15, 2006

   · 

  1 min read
• Drug Development

  Peregrine Pharmaceuticals, Inc.'s Anti-Phospholipid Technology Platform Broadened By Newly Validated Anti-Cancer Target

  September 15, 2006

   · 

  1 min read
• Business

  NEXUS Biosystems, Inc. and Covaris, Inc. Announce Marketing and Distribution Agreement Partnership

  September 15, 2006

   · 

  1 min read
• Devgen NV On Track In Implementation Of Business Plan

  September 15, 2006

   · 

  1 min read
• Business

  Array BioPharma, Inc. Receives Phase 2 Milestone Payment From AstraZeneca PLC

  September 15, 2006

   · 

  1 min read
• Drug Development

  MethylGene Initiates Phase II Clinical Trial With Proprietary HDAC Inhibitor, MGCD0103, In B-Cell Lymphoma

  September 15, 2006

   · 

  1 min read